Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women.

Tytuł:
Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women.
Autorzy:
Huffman KM; Physical Medicine and Rehabilitation, Veterans Affairs Medical Center, Durham, North Carolina, USA. />Shah SH
Stevens RD
Bain JR
Muehlbauer M
Slentz CA
Tanner CJ
Kuchibhatla M
Houmard JA
Newgard CB
Kraus WE
Źródło:
Diabetes care [Diabetes Care] 2009 Sep; Vol. 32 (9), pp. 1678-83. Date of Electronic Publication: 2009 Jun 05.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Publication: Alexandria Va : American Diabetes Association
Original Publication: New York, American Diabetes Assn.
MeSH Terms:
Insulin Resistance/*physiology
Obesity/*blood
Obesity/*physiopathology
Overweight/*blood
Overweight/*physiopathology
Adolescent ; Adult ; Aged ; Amino Acids/blood ; Blood Glucose ; Carnitine/analogs & derivatives ; Carnitine/blood ; Cross-Sectional Studies ; Fatty Acids, Nonesterified/blood ; Female ; Gas Chromatography-Mass Spectrometry ; Humans ; Male ; Middle Aged ; Principal Component Analysis ; Tandem Mass Spectrometry ; Young Adult
References:
J Clin Invest. 1998 Apr 1;101(7):1519-29. (PMID: 9525995)
Diabetes. 2006 Aug;55(8):2392-7. (PMID: 16873706)
CMAJ. 1991 Nov 15;145(10):1281-6. (PMID: 1933711)
J Endocrinol. 2002 Dec;175(3):757-67. (PMID: 12475386)
Diabetes. 2007 Jun;56(6):1489-501. (PMID: 17526912)
Diabetes. 2002 Jun;51(6):1907-12. (PMID: 12031980)
Pharmacol Res. 2008 Jan;57(1):6-18. (PMID: 18221886)
Contemp Clin Trials. 2005 Dec;26(6):616-25. (PMID: 16239128)
J Appl Physiol (1985). 2004 Jan;96(1):101-6. (PMID: 12972442)
J Biol Chem. 2004 Jun 25;279(26):27263-71. (PMID: 15073188)
Diabetes. 2002 Mar;51(3):599-605. (PMID: 11872656)
Am J Physiol Endocrinol Metab. 2000 Apr;278(4):E700-6. (PMID: 10751205)
Nat Rev Mol Cell Biol. 2008 Mar;9(3):193-205. (PMID: 18200017)
Circulation. 2008 May 6;117(18):2361-8. (PMID: 18427135)
Diabetes. 2004 Jul;53(7):1733-42. (PMID: 15220197)
OMICS. 2009 Feb;13(1):21-35. (PMID: 19290809)
Diabetes. 2003 Oct;52(10):2461-74. (PMID: 14514628)
Diabetes. 2000 Mar;49(3):399-408. (PMID: 10868961)
Cell Metab. 2009 Apr;9(4):311-26. (PMID: 19356713)
Nutr Rev. 1999 May;57(5 Pt 2):S2-9. (PMID: 10391020)
N Engl J Med. 1969 Oct 9;281(15):811-6. (PMID: 5809519)
Diabetes. 2001 Jun;50(6):1344-50. (PMID: 11375335)
Acta Physiol (Oxf). 2006 Jul;187(3):371-8. (PMID: 16776662)
Diabetes. 2005 Dec;54 Suppl 2:S97-107. (PMID: 16306347)
Clin Nutr. 2008 Jun;27(3):447-56. (PMID: 18342407)
Grant Information:
K23AR054904 United States AR NIAMS NIH HHS; R01 HL057354 United States HL NHLBI NIH HHS; R01 AG028930 United States AG NIA NIH HHS; R01HL-57354 United States HL NHLBI NIH HHS; K23 AR054904 United States AR NIAMS NIH HHS; P30 AGO28716-01 United States PHS HHS; P30 AG028716 United States AG NIA NIH HHS; AG028930-01 United States AG NIA NIH HHS
Substance Nomenclature:
0 (Amino Acids)
0 (Blood Glucose)
0 (Fatty Acids, Nonesterified)
0 (acylcarnitine)
S7UI8SM58A (Carnitine)
Entry Date(s):
Date Created: 20090609 Date Completed: 20091116 Latest Revision: 20220408
Update Code:
20240104
PubMed Central ID:
PMC2732163
DOI:
10.2337/dc08-2075
PMID:
19502541
Czasopismo naukowe
Objective: To determine whether circulating metabolic intermediates are related to insulin resistance and beta-cell dysfunction in individuals at risk for type 2 diabetes.
Research Design and Methods: In 73 sedentary, overweight to obese, dyslipidemic individuals, insulin action was derived from a frequently sampled intravenous glucose tolerance test. Plasma concentrations of 75 amino acids, acylcarnitines, free fatty acids, and conventional metabolites were measured with a targeted, mass spectrometry-based platform. Principal components analysis followed by backward stepwise linear regression was used to explore relationships between measures of insulin action and metabolic intermediates.
Results: The 75 metabolic intermediates clustered into 19 factors comprising biologically related intermediates. A factor containing large neutral amino acids was inversely related to insulin sensitivity (S(I)) (R(2) = 0.26). A factor containing fatty acids was inversely related to the acute insulin response to glucose (R(2) = 0.12). Both of these factors, age, and a factor containing medium-chain acylcarnitines and glucose were inversely and independently related to the disposition index (DI) (R(2) = 0.39). Sex differences were found for metabolic predictors of S(I) and DI.
Conclusions: In addition to the well-recognized risks for insulin resistance, elevated concentrations of large, neutral amino acids were independently associated with insulin resistance. Fatty acids were inversely related to the pancreatic response to glucose. Both large neutral amino acids and fatty acids were related to an appropriate pancreatic response, suggesting that these metabolic intermediates might play a role in the progression to type 2 diabetes, one by contributing to insulin resistance and the other to pancreatic failure. These intermediates might exert sex-specific effects on insulin action.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies